FBT (First Trust NYSE Arca Biotechnology Index Fund) Stock Analysis - Insider Trades

First Trust NYSE Arca Biotechnology Index Fund (FBT) is a publicly traded the market company. As of May 21, 2026, FBT trades at $204.57 with a market cap of $0 and a P/E ratio of 0.00. FBT moved +2.10% today. Year to date, FBT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces FBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading FBT stock inside the company?

Rallies tracks FBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

FBT Key Metrics

Key financial metrics for FBT
MetricValue
Price$204.57
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume112.87K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest FBT News

FBT Analyst Consensus

FBT analyst coverage data. Average price target: $0.00.

Common questions about FBT

Who is trading FBT stock inside the company?
Rallies tracks FBT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for FBT?
Yes. Rallies tracks FBT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is FBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FBT. It does not provide personalized investment advice.
FBT

FBT